Gene · 3937
Papers1,973
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 1,973
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mechanisms Underlying Dichotomous Procoagulant COAT Platelet Generation-A Conceptual Review Summarizing Current Knowledge. | Int J Mol Sci | 2022 | 35269679 | PubTator, text mining | PubMed |
| The Molecular Interaction of Collagen with Cell Receptors for Biological Function. | Polymers (Basel) | 2022 | 35267698 | PubTator, text mining | PubMed |
| Regulating the discriminatory response to antigen by T-cell receptor. | Biosci Rep | 2022 | 35260878 | PubTator, text mining | PubMed |
| Rap1 prevents colitogenic Th17 cell expansion and facilitates Treg cell differentiation and distal TCR signaling. | Commun Biol | 2022 | 35246619 | PubTator, text mining | PubMed |
| Novel long non-coding RNAs of relevance for ulcerative colitis pathogenesis. | Noncoding RNA Res | 2022 | 35224318 | PubTator, text mining | PubMed |
| Association of Tim-3/Gal-9 Axis with NLRC4 Inflammasome in Glioma Malignancy: Tim-3/Gal-9 Induce the NLRC4 Inflammasome. | Int J Mol Sci | 2022 | 35216164 | PubTator, text mining | PubMed |
| Impact of disease-modifying therapies on humoral and cellular immune-responses following SARS-CoV-2 vaccination in MS patients. | Clin Transl Sci | 2022 | 35213793 | PubTator, text mining | PubMed |
| Holistic View of ALK TKI Resistance in ALK-Positive Anaplastic Large Cell Lymphoma. | Front Oncol | 2022 | 35211406 | PubTator, text mining | PubMed |
| Current applications and future perspective of CRISPR/Cas9 gene editing in cancer. | Mol Cancer | 2022 | 35189910 | PubTator, text mining | PubMed |
| Bruton's tyrosine kinase inhibition-An emerging therapeutic strategy in immune-mediated dermatological conditions. | Allergy | 2022 | 35175630 | PubTator, text mining | PubMed |
| Immune cell type and DNA methylation vary with reproductive status in women: possible pathways for costs of reproduction. | Evol Med Public Health | 2022 | 35169479 | PubTator, text mining | PubMed |
| Molecular Aspects of Resistance to Immunotherapies-Advances in Understanding and Management of Diffuse Large B-Cell Lymphoma. | Int J Mol Sci | 2022 | 35163421 | PubTator, text mining | PubMed |
| Conformational switches that control the TEC kinase - PLCγ signaling axis. | J Struct Biol X | 2022 | 35128378 | PubTator, text mining | PubMed |
| Identification of the hub genes and transcription factor-miRNA axes involved in Helicobacter pylori-associated gastric cancer. | Oncol Lett | 2022 | 35126731 | PubTator, text mining | PubMed |
| In vitro reconstitution reveals cooperative mechanisms of adapter protein-mediated activation of phospholipase C-γ1 in T cells. | J Biol Chem | 2022 | 35124007 | PubTator, text mining | PubMed |
| CRISPR activation and interference screens decode stimulation responses in primary human T cells. | Science | 2022 | 35113687 | PubTator, text mining | PubMed |
| Inherited immunodeficiencies associated with proximal and distal defects in T cell receptor signaling and co-signaling. | Biomed J | 2022 | 35091087 | PubTator, text mining | PubMed |
| Chimeric antigen receptor engineered T cells and their application in the immunotherapy of solid tumours. | Expert Rev Mol Med | 2022 | 35086597 | PubTator, text mining | PubMed |
| Integrated analysis of differentially expressed genes, differentially methylated genes, and natural compounds in hepatitis C virus-induced cirrhosis. | J Int Med Res | 2022 | 35086375 | PubTator, text mining | PubMed |
| The role of SPI1-TYROBP-FCER1G network in oncogenesis and prognosis of osteosarcoma, and its association with immune infiltration. | BMC Cancer | 2022 | 35078433 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3937/papers?page=20